Capital Flow Monitor · Sponsors · CIK 2044678
Cultivation Capital Life Sciences Fund IV, LP
1100 CORPORATE SQUARE DRIVE, ST. LOUIS, MO, 63132 · 3142162051
Pooled Investment Fund / Venture Capital Fund · Limited Partnership· inc. DELAWARE true 2023
Fit score
—
Offering
$40.0M
Sold
$6.5M
% sold
16.3%
Investors
0
Min investment
$250K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-26 | D/A ·current | 506(b) | $40.0M | $6.5M | 16.3% | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- LLC Cultivation Capital — Promoter, Saint Louis, MO
- LLC Life Sciences Fund IV GP — Director, Saint Louis, MO
-
William Schmidt — Director / Promoter, Saint Louis, MO
1 other raise
- VedaPointe, Inc. $4.0M of $7.0M · 57.9%
-
Sean Morris — Director / Promoter, Saint Louis, MO
1 other raise
- Amplifi Vascular, Inc. $6.0M of $12.0M · 49.7%
- Catherine Matthes — Director / Promoter, Saint Louis, MO
- Joel Crater — Director / Promoter, Saint Louis, MO
- Scott Addonizio — Director / Promoter, Saint Louis, MO
-
David Narrow — Director / Promoter, Saint Louis, MO
1 other raise
- Sonavex, Inc. $3.1M of $15.0M · 20.7%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.